Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 657.80

+1.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: margie who wrote (254)	12/29/1998 12:50:00 AM
From: Miljenko Zuanic	Read Replies (1) of 3557

Thanks Margie. Unfortunately, REGN discontinue (for now, and I hope forever)development of the NT3 for diabetic neuropathy. REGN is currently running small PII trials for GI indications. Regards the VRTX and Timcodor I can't wait to se results. Never sow preclinical results, so do not know what to expect. Hoping for best. Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next